Cholangiocarcinoma in Denmark: Time-trends in incidence and mortality

Cholangiocarcinomas have a poor prognosis, and the incidence is rising in most countries. In Europe, all countries but Denmark have shown an increasing incidence of intrahepatic cholangiocarcinoma. The incidence of cholangiocarcinoma in Denmark between 1995 and 2022 increased, driven by a large increase in intrahepatic cholangiocarcinomas. The proportion with localised resectable disease increased while 1-year mortality decreased, though it remained high (65% in 2019-2022). Knowledge of incidence and mortality risk is valuable for doctors to understand the disease, identify risk factors, and design preventive care studies; for healthcare providers to allocate resources; and for patients to understand their prognosis.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-06-24
DOI
https://doi.org/10.1016/j.jhepr.2025.101493
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cholangiocarcinoma in Denmark: Time-trends in incidence and mortality

Frank Viborg Mortensen, Britta Weber, Joe West, Peter Jepsen et al.
JHEP Reports
Cholangiocarcinoma and Gallbladder Cancer Studies
article

Cholangiocarcinoma in Denmark: Time-trends in incidence and mortality

Frank Viborg Mortensen, Britta Weber, Joe West, Peter Jepsen, Morten Daniel Jensen
article en

Abstract

Cholangiocarcinomas have a poor prognosis, and the incidence is rising in most countries. In Europe, all countries but Denmark have shown an increasing incidence of intrahepatic cholangiocarcinoma. The incidence of cholangiocarcinoma in Denmark between 1995 and 2022 increased, driven by a large increase in intrahepatic cholangiocarcinomas. The proportion with localised resectable disease increased while 1-year mortality decreased, though it remained high (65% in 2019-2022). Knowledge of incidence and mortality risk is valuable for doctors to understand the disease, identify risk factors, and design preventive care studies; for healthcare providers to allocate resources; and for patients to understand their prognosis.

JHEP ReportsVol. 7(9)
Nottingham University Hospitals NHS Trust (GB), University of Nottingham (GB), Aarhus University (DK), Aarhus University Hospital (DK), Nottingham Biomedical Research Centre (GB)
Aarhus Universitet, Novo Nordisk, Novo Nordisk Fonden, Sundhedsvidenskabelige Fakultet, Aarhus Universitet
Good health and well-being
Openalex Percentile: Top 75%
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cholangiocarcinoma in Denmark: Time-trends in incidence and mortality — Frank Viborg Mortensen, Britta Weber, et al. · JHEP Reports (2025) | TGRS Research Map | TGRS